GRANNUS THERAPEUTICS, INC.
Mishawaka, IN · Founded 2020 · CIK 0001905806 · Biotech · Private
Targeted cancer therapeutics using novel oncology mechanisms
grannustherapeutics.com →- Grants
- $813K
- 3 awards
- Sector median: 1
- Raised
- $1.8M
- 2 Form D · Jan 2024
- 33 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of Hsp90 beta-selective inhibitors as safer anti-cancer agents | $233,195 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of Hsp90 beta-selective inhibitors as safer anti-cancer agents | $233,195 | |
| Federal grant | Department of Health and Human Services · Phase I · New Treatments for Glaucoma | $346,562 | |
| Private capital raised | Form D · SEC | $950,000 | |
| Private capital raised | Form D · SEC | $800,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1904 | NANOMEDTRIX LLC | — | — |
| 1905 | Hemispherian AS | — | $108K |
| 1906 | MBF THERAPEUTICS, INC. | — | $2.0M |
| 1907 | GRANNUS THERAPEUTICS, INC. | — | $1.8M |
| 1908 | Mitera Biosciences Inc. | — | $1.7M |
| 1909 | Regranion, LLC | — | — |
| 1910 | Yobee Care, Inc. | — | $1.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brian BlaggDirector
- John FoglesongDirector · Executive Officer
- James ThompsonDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.